Hepatitis - Pipeline Review, Q1 2011


February 28, 2011
31 Pages - SKU: GMD6185963
License type:
Table of Contents Search inside this report Related Reports
Introduction
Global Markets Direct Report Coverage
Hepatitis Overview
Therapeutics Development
An Overview of Pipeline Products for Hepatitis
Hepatitis Therapeutics under Development by Companies
Hepatitis Therapeutics under Investigation by Universities/Institutes
Companies Involved in Hepatitis Therapeutics Development
Tekmira Pharmaceuticals Corp.
Merck & Co., Inc.
Daewoong Pharmaceutical Co., Ltd.
Alfacell Corporation
CEL-SCI Corporation
Pacgen Biopharmaceuticals Corporation
Hanall Pharmaceutical Co., Ltd.
IRX Therapeutics, Inc.
Gaia BioPharma Limited
Universities/Institutes Involved in Hepatitis Therapeutics Development
Hepatitis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles - Companies
Hib/Hep B Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
IMD2 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Late Stage Drug Profiles - Universities/Institutes
Corticoids + N Acetyl Cysteine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pioglitazone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products Under Development for Hepatitis, 2011
Products under Development for Hepatitis - Comparative Analysis, 2011
Tekmira Pharmaceuticals Corp., 2011
Merck & Co., Inc., 2011
Daewoong Pharmaceutical Co., Ltd., 2011
Alfacell Corporation, 2011
CEL-SCI Corporation, 2011
Pacgen Biopharmaceuticals Corporation, 2011
Hanall Pharmaceutical Co., Ltd., 2011
IRX Therapeutics, Inc., 2011
Gaia BioPharma Limited, 2011
Assessment by Monotherapy Products, 2011
Assessment by Combination Products
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
List of Figures
Number of Products under Development for Hepatitis, 2011
Products under Development for Hepatitis - Comparative Analysis, 2011
Products under Development by Companies, 2011
Products under Investigation by Universities/Institutes, 2011
Assessment by Monotherapy Products, 2011
Assessment by Combination Products, 2011
Assessment by Route of Administration, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Assessment by Stage and Molecule Type, 2011
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Drug Discovery Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!